ENGN SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on · accession 0001140361-26-032512

ENGN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -6.6% by the first close after the filing.

Summary of the filing

An institutional holder filed an amended Schedule 13G disclosing its passive ownership position in enGene Therapeutics Inc. The filing indicates a change in the holder's previously reported beneficial ownership.

Key details

IssuerenGene Therapeutics Inc.

How ENGN stock reacted

Close before

$1.82

Aug 11, 2026

First close after

-6.59%

$1.70

5 trading days

-5.49%

$1.72

Since filing

-3.85%

$1.75

✦ Ask GOAX AI about this filing — what it means for ENGN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ENGN?

Click here

Frequently asked questions

What did ENGN file with the SEC on Aug 12, 2026?

ENGN filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing its passive ownership position in enGene Therapeutics Inc. The filing indicates a change in the holder's previously reported beneficial ownership.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ENGN stock react to this filing?

ENGN closed at $1.82 before the filing and $1.70 on Aug 12, 2026 (-6.59%). Five trading days later: $1.72 (-5.49%).

Other ENGN SEC filings

Get alerts when ENGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days